Financial Performance Highlights - Net income attributable to Unitholders for the three months ended March 31, 2025, was $80 million ($0.38 per limited partnership unit), compared to $48 million ($0.23 per limited partnership unit) in the prior period[12, 19] - Adjusted EBITDA for the three months ended March 31, 2025, was $591 million, compared to $544 million in the prior period[12, 19] - Adjusted EFO for the three months ended March 31, 2025, was $345 million ($1.60 per unit), compared to $331 million ($1.53 per unit) in the prior period[19] - Corporate liquidity as of March 31, 2025, was $2,414 million, including $59 million of cash and liquid securities and $2,330 million of availability on credit facilities[19, 24] Segment Performance - Business Services Adjusted EBITDA was $213 million, compared to $205 million in the prior period[13, 45] - Infrastructure Services Adjusted EBITDA was $104 million, compared to $143 million in the prior period, which included contribution from the shuttle tanker operation in offshore oil services that was sold in January 2025[13, 49] - Industrials Adjusted EBITDA was $304 million, compared to $228 million in the prior period, with the advanced energy storage operation contributing $233 million compared to $159 million in the prior period[13, 54] Balance Sheet and Liquidity - Total assets as of March 31, 2025, were $75,887 million, compared to $75,474 million as of December 31, 2024[23] - Non-recourse borrowings in subsidiaries were $42,316 million as of March 31, 2025, compared to $36,720 million as of December 31, 2024[23] - Corporate borrowings were $1,017 million as of March 31, 2025, compared to $2,142 million as of December 31, 2024[23] Capital Structure - Partnership units outstanding were 141.0 million as of March 31, 2025, compared to 144.0 million as of December 31, 2024[30] - BBUC exchangeable shares outstanding were 71.7 million as of March 31, 2025, compared to 73.0 million as of December 31, 2024[30] - The company invested approximately $140 million to repurchase 5.9 million of its units and shares at an average price of approximately $24 per unit and share during the quarter and subsequent to quarter end[22]

Core Insights - Brookfield Business Partners reported a net income of $80 million for Q1 2025, up from $48 million in Q1 2024, reflecting a significant increase in profitability [2][3][31] - The company generated over $1.5 billion from capital recycling initiatives and invested approximately $140 million in unit and share repurchases [2][9] - Adjusted EBITDA for Q1 2025 was $591 million, compared to $544 million in the prior year, driven by strong performance in the Industrials segment [3][4] Financial Performance - Net income attributable to unitholders for Q1 2025 was $80 million ($0.38 per unit), compared to $48 million ($0.23 per unit) in Q1 2024 [2][3] - Adjusted EBITDA increased to $591 million in Q1 2025 from $544 million in Q1 2024, with contributions from recent acquisitions [3][4] - The Industrials segment generated $304 million in Adjusted EBITDA, up from $228 million in the same period last year, aided by tax benefits and new acquisitions [4][5] Segment Performance - Business Services segment reported Adjusted EBITDA of $213 million, slightly up from $205 million in Q1 2024, despite higher technology upgrade costs [5] - Infrastructure Services segment saw a decline in Adjusted EBITDA to $104 million from $143 million, impacted by the sale of the offshore oil services operation [6] - Adjusted EFO for the Industrials segment decreased to $130 million from $180 million, reflecting the impact of withholding taxes [7] Strategic Initiatives - The company announced the acquisition of Antylia Scientific for approximately $1.3 billion, with Brookfield expected to invest about $160 million for a 25% interest [8] - A unit repurchase program was executed, with approximately $140 million spent to repurchase 5.9 million units at an average price of $24 per unit [9] Liquidity and Distribution - As of March 31, 2025, Brookfield had approximately $2.4 billion in liquidity, including $59 million in cash and liquid securities [10] - The Board declared a quarterly distribution of $0.0625 per unit, payable on June 30, 2025 [11][33]

Core Viewpoint - BrightSpring Health Services, Inc. reported strong financial results for Q1 2025, with significant increases in revenue and adjusted EBITDA, and has raised its full-year guidance for revenue and adjusted EBITDA [1][6]. Financial Performance - Net Revenue for Q1 2025 reached $2,878 million, a 25.9% increase from $2,286 million in Q1 2024 [3][6]. - Gross Profit for the same period was $338 million, up 15.7% from $292 million in Q1 2024 [3][6]. - Net Income from Continuing Operations was $9.2 million, a turnaround from a Net Loss of $56.0 million in Q1 2024 [3][6]. - Adjusted EBITDA for Q1 2025 was $131 million, reflecting a 28.2% increase compared to $102 million in Q1 2024 [4][6]. Segment Performance - Pharmacy Solutions Revenue was $2,532 million, up 28% from $1,977 million in Q1 2024 [5]. - Provider Services Revenue increased by 12% to $346 million from $309 million in Q1 2024 [5]. Guidance and Future Outlook - The company has increased its 2025 Revenue guidance to a range of $12,000 million to $12,500 million, representing a growth of 19.1% to 24.1% [6][14]. - Adjusted EBITDA guidance for 2025 is now set at $570 million to $585 million, indicating a growth of 23.9% to 27.2% [6][14]. Strategic Initiatives - The planned divestiture of the Community Living business to Sevita is on track to be completed within the year [6].

Core Insights - Shell plc reported a significant increase in income attributable to shareholders, reaching $4.78 billion in Q1 2025, compared to $928 million in Q4 2024 and $7.36 billion in Q1 2024, reflecting a 415% increase from the previous quarter [1] - Adjusted Earnings for Q1 2025 were $5.58 billion, a 52% increase from $3.66 billion in Q4 2024, while Adjusted EBITDA rose to $15.25 billion, a 7% increase from $14.28 billion in the previous quarter [1] - Cash flow from operating activities decreased by 29% to $9.28 billion compared to $13.16 billion in Q4 2024, primarily due to tax payments and working capital outflows [1][4] Financial Performance - Total revenue for Q1 2025 was $70.15 billion, an increase from $66.81 billion in Q4 2024 [71] - The company reported a basic earnings per share of $0.79, up from $0.15 in Q4 2024 [1] - Total debt at the end of Q1 2025 was $76.51 billion, with net debt increasing to $41.52 billion from $38.81 billion in Q4 2024, resulting in a gearing ratio of 18.7% [1][6] Segment Analysis Integrated Gas - Income for the Integrated Gas segment was $2.79 billion, up 60% from $1.74 billion in Q4 2024, driven by lower exploration well write-offs and higher product margins [18][21] - Adjusted Earnings for this segment increased to $2.48 billion, a 15% rise from $2.17 billion in the previous quarter [18] Upstream - The Upstream segment reported income of $2.08 billion, a 102% increase from $1.03 billion in Q4 2024, attributed to lower exploration well write-offs and favorable tax movements [27][29] - Adjusted Earnings rose to $2.34 billion, a 39% increase from $1.68 billion in Q4 2024 [27] Marketing - The Marketing segment's income was $814 million, a significant increase from $103 million in Q4 2024, driven by lower operating expenses and higher marketing margins [34][37] - Adjusted Earnings for this segment were $900 million, reflecting a 7% increase from $839 million in the previous quarter [34] Chemicals and Products - The Chemicals and Products segment reported a loss of $77 million, an improvement from a loss of $276 million in Q4 2024, driven by higher product margins [42][44] - Adjusted Earnings for this segment were $449 million, a substantial increase from a loss of $229 million in the previous quarter [42] Renewables and Energy Solutions - The Renewables and Energy Solutions segment reported a loss of $247 million, an improvement from a loss of $1.23 billion in Q4 2024, primarily due to higher trading and optimization margins [50][55] - Adjusted Earnings were negative at $42 million, compared to a loss of $311 million in the previous quarter [50] Shareholder Distributions - Total shareholder distributions in Q1 2025 amounted to $5.5 billion, including $3.3 billion in share repurchases and $2.2 billion in cash dividends [7] - The dividend declared for Q1 2025 was $0.3580 per share, consistent with the previous quarter [1][7] Outlook - For the full year 2025, Shell expects cash capital expenditure to be between $20 billion and $22 billion [64] - Integrated Gas production is projected to be approximately 890 - 950 thousand boe/d, while Upstream production is expected to be around 1,560 - 1,760 thousand boe/d [65][66]

Financial Performance - Sales from continuing operations for Q1 2025 were $131.7 million, a slight increase of 0.4% compared to $131.2 million in Q1 2024 [3][7] - Adjusted EBITDA decreased to $2.3 million, representing a margin of 1.7%, down from $4.9 million and a margin of 3.7% in the same period last year [3][9] - The net loss from continuing operations was $4.0 million, compared to a loss of $1.8 million in Q1 2024 [3][10] - Cash flow from operating activities decreased to $6.2 million from $11.7 million in the prior year [3][11] Financial Position - As of March 22, 2025, net debt was reduced to $47.1 million from $47.8 million at the end of 2024 [3][12] - The financial leverage ratio increased to 2.8x from 2.4x [3][4] - Working capital decreased to $45.8 million from $50.3 million at the end of the previous fiscal year, attributed to seasonal effects [11][12] Market Dynamics - The growth in purchasing volume with distribution clients is helping the company gain market share despite a slowdown in the restaurant industry [5] - The renewal of a supply agreement with an institutional client at lower margins than in 2024 is impacting financial performance [8][9] - Wholesale activities sales decreased by 3.8%, primarily due to the slowdown in the restaurant industry [8] Strategic Initiatives - The company announced an agreement to acquire the food distribution assets of Alimplus Inc. and its subsidiary Tout-Prêt Inc. for $51.5 million, pending closing conditions [7] - Management is focusing on sound financial management and aims to improve product and customer mix to mitigate the impact of lower-margin contracts [13]

Core Insights - The AES Corporation reported a net loss of $73 million for Q1 2025, a significant decline from a net income of $278 million in Q1 2024, primarily due to higher prior year revenues from the monetization of the Warrior Run coal plant PPA and one-time restructuring costs [3][6][10] - The company reaffirmed its 2025 guidance for Adjusted EBITDA between $2,650 million and $2,850 million, with expected growth driven by new renewable projects and rate base growth at U.S. utilities [8][9][10] Strategic Accomplishments - The company completed the construction of 643 MW of energy storage and solar projects and is on track to add a total of 3.2 GW of new projects by the end of 2025 [10][11] - AES signed or awarded new long-term Power Purchase Agreements (PPAs) for 443 MW of solar and energy storage [10][11] - The sale of a minority interest in AES Global Insurance Company (AGIC) for $450 million helped achieve the full-year asset sale proceeds target of $400 to $500 million [10][11] Financial Highlights - Q1 2025 Adjusted EBITDA was $591 million, down from $640 million in Q1 2024, mainly due to lower contributions from the Energy Infrastructure SBU [4][7] - Adjusted EPS for Q1 2025 was $0.27, a decrease from $0.50 in Q1 2024, driven by lower realized tax attributes and contributions from the Energy Infrastructure SBU [7][10] - The company reported total revenue of $2,926 million for Q1 2025, compared to $3,085 million in Q1 2024, reflecting a decline in both regulated and non-regulated revenue streams [24][25] Financial Position and Outlook - The company reaffirmed its expectation for annualized growth in Adjusted EBITDA of 5% to 7% through 2027, based on a 2023 guidance base of $2,600 million to $2,900 million [9][10] - The total assets of the company increased to $48,615 million as of March 31, 2025, compared to $47,406 million at the end of 2024 [26][27] - The company expects to maintain its quarterly dividend payment of $0.17595 going forward [13]

Core Viewpoint - Select Medical Holdings Corporation reported a 2.4% increase in revenue for Q1 2025, alongside a significant rise in net income from continuing operations, indicating a positive financial trajectory despite challenges in certain segments [2][12]. Financial Performance - Revenue for Q1 2025 reached $1,353.2 million, up from $1,321.2 million in Q1 2024 [2]. - Income from continuing operations before other income and expense was $112.7 million, a decrease from $118.5 million year-over-year [2]. - Net income from continuing operations increased by 21.5% to $74.7 million compared to $61.5 million in the prior year [2]. - Adjusted EBITDA for Q1 2025 was $151.4 million, down from $165.8 million in Q1 2024 [2]. - Earnings per share from continuing operations rose by 33.3% to $0.44, compared to $0.33 in the same quarter last year [2]. Segment Performance - **Critical Illness Recovery Hospital Segment**: Revenue decreased by 2.9% to $637.0 million, with Adjusted EBITDA down 25.3% to $86.6 million [5][23]. - **Rehabilitation Hospital Segment**: Revenue increased by 15.7% to $307.4 million, with Adjusted EBITDA rising by 14.7% to $70.4 million [6][23]. - **Outpatient Rehabilitation Segment**: Revenue increased by 1.4% to $307.3 million, while Adjusted EBITDA slightly decreased to $24.3 million [7][24]. Company Overview - Select Medical operates 104 critical illness recovery hospitals, 35 rehabilitation hospitals, and 1,911 outpatient rehabilitation clinics across 40 states and the District of Columbia as of March 31, 2025 [4]. Dividend and Stock Repurchase - The Board of Directors declared a cash dividend of $0.0625 per share, payable on or about May 29, 2025 [8]. - A stock repurchase program was authorized for up to $1.0 billion, with 649,804 shares repurchased at a cost of approximately $11.4 million during Q1 2025 [10][11]. Business Outlook - For fiscal year 2025, Select Medical expects revenue between $5.3 billion and $5.5 billion, Adjusted EBITDA between $510 million and $530 million, and fully diluted earnings per share between $1.09 and $1.19 [12].

Core Insights - Huntsman Corporation reported first quarter 2025 revenues of $1,410 million, a decrease of 4% compared to $1,470 million in the same period of 2024 [2][11] - The net loss attributable to Huntsman was $5 million, significantly improved from a net loss of $37 million in the prior year [11] - Adjusted EBITDA for the first quarter of 2025 was $72 million, down from $81 million in the same period of 2024, reflecting an 11% decline [11][17] Financial Performance - Revenues decreased across all segments: Polyurethanes by 2% to $912 million, Performance Products by 12% to $257 million, and Advanced Materials by 5% to $249 million [16][17] - Adjusted net loss for the first quarter was $19 million, compared to an adjusted net loss of $11 million in the prior year [11][17] - The diluted loss per share improved to $0.03 from $0.22 year-over-year [11] Segment Analysis - In the Polyurethanes segment, lower average selling prices were partially offset by higher sales volumes, leading to an increase in adjusted EBITDA by 8% [4] - The Performance Products segment saw a decrease in revenues primarily due to lower sales volumes and unplanned production outages, resulting in a 29% drop in adjusted EBITDA [5] - Advanced Materials experienced a decline in revenues due to lower average selling prices, with adjusted EBITDA decreasing by 16% [6] Liquidity and Capital Resources - Free cash flow used in continuing operations was $107 million, slightly higher than the $105 million used in the same period of 2024 [8][11] - As of March 31, 2025, Huntsman had approximately $1.3 billion in combined cash and unused borrowing capacity [8] Management Commentary - The CEO noted significant changes in short-term business conditions, with low visibility and customer uncertainty impacting demand trends in key markets [3] - The company is focusing on cost management, including workforce reductions and asset optimization, while prioritizing balance sheet protection and cash generation [3]

Financial Results - Elme Communities reported a net loss per diluted share of $0.05 for Q1 2025, compared to a loss of $0.04 in Q1 2024 [2][21] - Core FFO per diluted share increased to $0.24 in Q1 2025 from $0.23 in Q1 2024 [2][21] Operational Highlights - Same-store multifamily NOI increased by 5.5% year-over-year, driven by higher rental revenue and successful property tax assessment appeals [7][8] - Average occupancy for the same-store portfolio rose to 94.8%, up 0.5% from the prior year [7][8] - Retention rate during the quarter was 62%, aligning with expectations [7] Balance Sheet - As of March 31, 2025, available liquidity was $324 million, consisting of cash and availability under the revolving credit facility [7] - The annualized Net Debt to Adjusted EBITDA ratio was 5.6x, indicating a strong balance sheet with only $125 million of debt maturing before 2028 [7] Strategic Review - The board of trustees initiated a formal review to evaluate strategic alternatives for maximizing shareholder value, with no set deadline for completion [6] 2025 Guidance - Elme expects Core FFO for 2025 to range from $0.91 to $0.97 per fully diluted share [9][10] - Same-store multifamily revenue growth is projected between 2.1% and 3.6%, with NOI growth expected to be between 1.5% and 3.5% [10] Dividends - Elme Communities paid a quarterly dividend of $0.18 per share on April 3, 2025, and announced another dividend of the same amount to be paid on July 3, 2025 [12]

Core Insights - RE/MAX Holdings reported a net loss of $2.0 million for Q1 2025, an improvement from a net loss of $3.4 million in Q1 2024, with basic and diluted GAAP loss per share at $(0.10) compared to $(0.18) in the prior year [8][10][12] Group 1: Operating Results - Total revenue for Q1 2025 was $74.5 million, down 4.9% from $78.3 million in Q1 2024, with revenue excluding Marketing Funds at $55.6 million, a decrease of 4.3% [4][10] - The agent count as of March 31, 2025, was 146,126, reflecting a 2.0% increase from 143,287 in the previous year, while the U.S. and Canada combined agent count decreased by 5.0% to 75,010 [3][10] Group 2: Revenue and Expenses - Recurring revenue streams, including franchise fees and annual dues, decreased by $2.2 million, or 5.5%, accounting for 66.8% of revenue excluding Marketing Funds in Q1 2025 [5] - Total operating expenses were $69.1 million, down 6.3% from $73.8 million in Q1 2024, primarily due to lower selling, operating, and administrative expenses [6][10] Group 3: Adjusted Metrics - Adjusted EBITDA for Q1 2025 was $19.3 million, an increase of 1.5% from $18.993 million in Q1 2024, with an adjusted EBITDA margin of 25.9% compared to 24.3% in the prior year [11][30] - Adjusted basic and diluted EPS were both $0.24 for Q1 2025, up from $0.20 in Q1 2024 [12][33] Group 4: Balance Sheet and Cash Flow - As of March 31, 2025, the company had cash and cash equivalents of $89.1 million, a decrease of $7.5 million from December 31, 2024, with outstanding debt at $439.9 million [13][26] - Cash flow from operations for Q1 2025 was $5.661 million, down from $9.381 million in Q1 2024, with adjusted free cash flow at $(1.161) million compared to $4.543 million in the prior year [28][38] Group 5: Outlook - For Q2 2025, the company expects agent count to increase by 1.5% to 2.5% and revenue in the range of $70.0 million to $75.0 million, with adjusted EBITDA projected between $22.5 million and $25.5 million [20]